|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09995 REMEGEN
Nominal 
() Ranking Overview
Ranking based on 11 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
11
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2022 | EPS | -188.00 RMB (cts) | |
| Net Profit | -998.83 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2023 | -1,085.82 | -200.00 | 0 | -- | -748.00 | -1,453.00 |
| 2024 | -819.00 | -150.50 | 0 | -- | -179.00 | -1,384.00 |
| 2025 | -155.00 | -28.60 | 0 | -- | 1,495.00 | -792.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2023 | -1,022.00 | -188.00 | -- | CHINA SEC INT'L BRO | Buy | 70.80 | (6M) | 19/06/2023 |
| 2023 | -993.00 | -182.40 | -- | CITIGROUP | Buy | 65.00 | 23/08/2023 | |
| 2023 | -811.00 | -149.00 | -- | CLSA | Buy | 64.80 | 28/04/2023 | |
| 2023 | -1,429.00 | -266.00 | -- | UBS | Buy | 63.70 | 21/08/2023 | |
| 2023 | -1,453.00 | -270.00 | -- | MACQUARIE | OutPerform | 63.00 | 21/08/2023 | |
| 2023 | -923.00 | -170.00 | -- | MORGAN STANLEY | Overweight | 62.00 | 22/08/2023 | |
| 2023 | -748.00 | -141.00 | -- | BOCOM | Buy | 60.00 | 01/08/2023 | |
| 2023 | -1,447.00 | -266.00 | -- | CMB INT'L SEC | Buy | 55.54 | 23/08/2023 | |
| 2023 | -1,241.00 | -228.10 | -- | BOCI | Buy | 53.00 | 24/08/2023 | |
| 2023 | -1,085.82 | -200.00 | -- | FIRST SHANGHAI SEC | Buy | 48.90 | 18/09/2023 | |
| 2023 | -1,145.00 | -210.40 | -- | DAIWA | OutPerform | 37.50 | 07/09/2023 | |
| 2024 | -718.00 | -132.00 | -- | CHINA SEC INT'L BRO | -- | -- | 19/06/2023 | |
| 2024 | -819.00 | -150.50 | -- | CITIGROUP | -- | -- | 23/08/2023 | |
| 2024 | -179.00 | -33.00 | -- | CLSA | -- | -- | 28/04/2023 | |
| 2024 | -1,384.00 | -254.00 | -- | UBS | -- | -- | 21/08/2023 | |
| 2024 | -1,037.00 | -190.00 | -- | MACQUARIE | -- | -- | 21/08/2023 | |
| 2024 | -526.00 | -97.00 | -- | MORGAN STANLEY | -- | -- | 22/08/2023 | |
| 2024 | -320.00 | -60.00 | -- | BOCOM | -- | -- | 01/08/2023 | |
| 2024 | -1,201.00 | -221.00 | -- | CMB INT'L SEC | -- | -- | 23/08/2023 | |
| 2024 | -699.00 | -128.50 | -- | BOCI | -- | -- | 24/08/2023 | |
| 2024 | -1,018.78 | -187.00 | -- | FIRST SHANGHAI SEC | -- | -- | 18/09/2023 | |
| 2024 | -849.00 | -156.00 | -- | DAIWA | -- | -- | 07/09/2023 | |
| 2025 | 31.00 | 6.00 | -- | CHINA SEC INT'L BRO | -- | -- | 19/06/2023 | |
| 2025 | -140.00 | -25.80 | -- | CITIGROUP | -- | -- | 23/08/2023 | |
| 2025 | 837.00 | 154.00 | -- | CLSA | -- | -- | 28/04/2023 | |
| 2025 | -618.00 | -114.00 | -- | UBS | -- | -- | 21/08/2023 | |
| 2025 | -792.00 | -150.00 | -- | MACQUARIE | -- | -- | 21/08/2023 | |
| 2025 | 1,495.00 | 275.00 | -- | MORGAN STANLEY | -- | -- | 22/08/2023 | |
| 2025 | 298.00 | 56.00 | -- | BOCOM | -- | -- | 01/08/2023 | |
| 2025 | -766.00 | -141.00 | -- | CMB INT'L SEC | -- | -- | 23/08/2023 | |
| 2025 | -155.00 | -28.60 | -- | BOCI | -- | -- | 24/08/2023 | |
| 2025 | -529.54 | -97.00 | -- | FIRST SHANGHAI SEC | -- | -- | 18/09/2023 | |
| 2025 | -400.00 | -73.50 | -- | DAIWA | -- | -- | 07/09/2023 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: -- | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -703,362,000 |
| %Change | 43.800% |
| EPS / (LPS) | RMB -1.300 |
| NBV Per Share (¥) | RMB 7.892 |